News Years after Pfizer merger, ex-Medivation exec gets insider t... A Medivation executive at the heart of the company's team that sold the company to Pfizer for $14 billion five years ago is facing allegations of insider trading.
Views & Analysis Why does UK biotech struggle to generate leaders? Can the UK emulate America's culture of biotech entrepreneurship?
News Takeda earmarks $15 billion for M&A - reports Japanese company could be on the acquisition trail.
News Merck, Pfizer and Gilead all interested in Medivation buy-ou... Sanofi has competition in its bid to acquire cancer specialist
Digital Chaos & opportunity: Dr Adam Brown unpacks US health policy Dive into our video interview with Dr Adam Brown as he unpacks the chaos and opportunity shaping US health policy.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face